Ignite Creation Date:
2024-05-06 @ 11:10 AM
Last Modification Date:
2024-10-26 @ 12:40 PM
Study NCT ID:
NCT03443076
Status:
COMPLETED
Last Update Posted:
2023-03-23
First Post:
2018-02-16
Brief Title:
Bioavailability of EPA DHA in a SMEDS Formulation
Sponsor:
Midwest Center for Metabolic and Cardiovascular Research
Organization:
Midwest Center for Metabolic and Cardiovascular Research
Study Overview
Official Title:
A Randomized Crossover Study to Assess the Relative Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid in a Self-micro-emulsifying Delivery System SMEDS Formulation Compared With a Standard Omega-3-acid Ethyl Ester Product
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will assess the relative bioavailability of 500 mg eicosapentaenoic acid EPA docosahexaenoic acid DHA in a self-micro-emulsifying delivery system SMEDS formulation compared with a standard omega-3-acid ethyl ester product in healthy men and women
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None